SAVANNA MISCIAGNA: Open Payments
NPI 1740042472 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,993 in 150 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,740 · 2025 $2,993
Food & beverage: $2,993
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $315 |
| Neurocrine BioSciences, Inc. | 11 | $311 |
| Lundbeck LLC | 12 | $284 |
| Alkermes, Inc. | 12 | $270 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $250 |
| ABBVIE INC. | 17 | $209 |
| Otsuka America Pharmaceutical, Inc. | 10 | $200 |
| Axsome Therapeutics, Inc. | 9 | $176 |
| Vanda Pharmaceuticals Inc. | 7 | $173 |
| E.R. Squibb & Sons, L.L.C. | 11 | $169 |
Products named: REXULTI, INGREZZA, INVEGA SUSTENNA, ARISTADA, CAPLYTA, VRAYLAR, Auvelity, COBENFY.
Industry payments across FL — which companies pay providers there.
